INTRODUCTION
The endocytosis of immunity-related receptors has emerged as a critical control step in the signal transduction process. The first receptors activated during any host-pathogen interaction are members of the Toll-like Receptor (TLR) family, which are responsible for detecting microbial products and inducing innate and adaptive immunity (Akira and Takeda, 2004) . Different TLR family members are found in different subcellular compartments, ranging from the plasma membrane to early, late, and recycling endosomes (Barton and Kagan, 2009) . While it was believed originally that the endocytosis of plasma membrane-localized TLRs downregulates their signaling functions after a microbial encounter (Husebye et al., 2006; Latz et al., 2003) , new evidence indicates that receptor delivery to endosomes also activates specific signal transduction pathways (Kagan et al., 2008; Tanimura et al., 2008) .
Virtually all of our knowledge of TLR transport is limited to regulators that promote the folding or transport of newly synthesized receptors (e.g., GP96, PRAT4a, and UNC93B1) (Kim et al., 2008; Takahashi et al., 2007; Yang et al., 2007) . In the absence of each of these regulators, specific sets of TLRs cannot exit the endoplasmic reticulum after translation and, consequently, TLR ligands present in the extracellular and endosomal spaces are not detected. Unlike the emerging knowledge on the trafficking of newly synthesized receptors, almost nothing is known about the regulators that control TLR endocytosis or transport after microbial detection. Filling this gap in our knowledge is of fundamental importance, as microbe-induced receptor transport is a critical control step in TLR-mediated signal transduction.
The first-described example of microbe-induced TLR transport came from studies of the LPS receptor TLR4, which induces distinct signaling pathways from two different organelles (Kagan et al., 2008; Tanimura et al., 2008) . The first signaling pathway is activated from the plasma membrane after TLR4 encounters LPS (Latz et al., 2003) . This pathway is mediated by a pair of sorting and signaling adaptor proteins called TIRAP and MyD88, respectively (Kagan and Medzhitov, 2006) . These adaptors induce proinflammatory cytokine expression by linking TLR4 to downstream enzymes that activate NF-kB and AP-1 (Akira and Takeda, 2004) . TLR4 is then internalized into the endosomal network where the second signaling pathway is triggered through the adaptors TRAM and TRIF (Kagan et al., 2008; Tanimura et al., 2008) . These adaptors mediate the activation of the transcription factor Interferon Regulatory Factor-3 (IRF3), which regulates Type I Interferon (IFN) expression (Akira and Takeda, 2004) . Thus, in the case of TLR4, the LPS-induced endocytosis of the receptor is essential for its signaling functions. While the general endocytic machinery is undoubtedly involved in internalization of plasma membrane-localized TLRs, there are no known membrane proteins that regulate TLR endocytosis specifically upon microbial recognition.
In considering this problem, we reasoned that since TRIF-mediated IFN expression requires TLR4 endocytosis, cell surface proteins that control endosomal signaling may do so by regulating TLR4 entry into the cell. One such regulator is CD14. CD14 is a GPI-linked protein that is found on the surface of many (but not all) TLR4 expressing cells (Wright et al., 1990) . CD14 was the first identified Pattern Recognition Receptor (PRR) that binds directly to LPS (Wright et al., 1990) , and is known to chaperone LPS molecules to the TLR4-MD-2 signaling complex (da Silva Correia et al., 2001; Gioannini et al., 2004; Moore et al., 2000) . Notably, while CD14 is marginally important for MyD88-dependent TNFa expression, it is essential for TRIF-mediated IFN expression (Jiang et al., 2005) . Thus, we hypothesized that CD14 specifically regulates TRIF-mediated IFN expression because it regulates TLR4 endocytosis. Here, we show that this prediction is correct and that CD14 controls a microbe-specific endocytosis pathway that functions to internalize both TLR4 and promote TRIF-mediated signal transduction. Remarkably, TLR4 is internalized independently of its signaling functions but dependent on regulators of Fc Receptor and Dectin-1-mediated endocytosis. Collectively, these data suggest the existence of an inflammatory endocytosis pathway that can be activated by multiple upstream receptors to promote antimicrobial immunity.
RESULTS

CD14 Is Required for LPS-Induced TLR4 Endocytosis
To identify proteins that specifically regulate the LPS-induced endocytosis of TLR4, we used a highly sensitive assay to detect endogenous TLR4 by flow cytometry. Using the loss of cell surface expression as a readout for TLR4 endocytosis, we (A and B) WT or CD14-deficient (KO) mouse BMDM (A) or DCs (B) were untreated or treated with LPS (1 mg/ml) for the times indicated. Flow cytometry was then used to examine receptor endocytosis by determining the surface levels of the endogenous proteins indicated. The third and fourth panels in (A) and (B) represent the mean fluorescence intensity (MFI) of specific receptor staining at each time point. (C and D) BMDM (C) or DCs (D) were treated with the concentrations of LPS indicated for 18 hr and the amounts of secreted cytokines were determined. (E and F) BMDM (E) or DCs (F) were treated with LPS (1 mg/ml) for the times indicated and the presence of active (dimerized) IRF3 in cell extracts was determined by native PAGE. See also Figure S1 .
showed previously that LPS induces TLR4 internalization in mouse bone marrow derived macrophages (BMDM) (Kagan et al., 2008) . The loss of TLR4 surface staining was a bona fide endocytic event as it was inhibited by dynasore (Kagan et al., 2008) , an inhibitor of dynamin GTPases that control most endocytic processes in mammalian cells. Using this assay, we determined if CD14 regulates TLR4 transport as a means of controlling IFN production.
LPS-induced TLR4 endocytosis was examined in BMDM and immature dendritic cells (DCs) from wild-type (WT) and CD14-deficient mice. LPS induced the rapid endocytosis of TLR4 in WT BMDM and DCs, but not in cells from CD14-deficient mice ( Figures 1A and 1B) . The endocytosis of TLR4 was a specific response, as levels of a different endocytic receptor (FcgR1) were largely unaffected by LPS treatment (Figures 1A and 1B) . To complement this FACS-based assay, TRIF-mediated signaling events from endosomes were examined (Kagan et al., 2008) . CD14-deficient BMDM and DCs were defective for TRIF-mediated IFN production but were not defective for MyD88-mediated TNFa production ( Figures 1C and 1D ). Of note, at low LPS concentrations, CD14 was needed for TNFa production, which likely reflects its role in delivering LPS to TLR4 (da Silva Correia et al., 2001; Gioannini et al., 2004) .
To more specifically address the role of CD14 in signaling from the plasma membrane or endosomes, we examined protein complexes that define each pathway. TLR4 signaling from the plasma membrane induces the formation of the Myddosome, a complex containing MyD88 and IRAK4 that activates NF-kB (Motshwene et al., 2009 ). TLR4 signaling from endosomes induces the dimerization of the transcription factor IRF3 (Kagan et al., 2008) . We monitored the formation of the Myddosome by coimmunoprecipitations of MyD88 and IRAK4 in WT and CD14-deficient immature DCs. LPS treated WT and CD14-deficient DCs induced Myddosome formation (Figure S1A available online), suggesting that TLR4 signaling from the plasma membrane does not absolutely require CD14. In addition, CD14-deficient cells retained the ability to activate the MAP kinases p38 and ERK1/2 and induce IkBa degradation in response to LPS treatment (Figures S1B and S1C) . In contrast to the signaling events occurring at the plasma membrane, LPSinduced dimerization of IRF3 was not detected in either CD14-deficient BMDM or DCs ( Figures 1E and 1F) . Collectively, using both direct assays of TLR4 endocytosis and assays of signaling events that occur only after endocytosis, these data establish that CD14 is required for LPS-induced endocytosis of TLR4.
In addition to TLR4, TLR2 signaling in inflammatory monocytes and BMDM can induce IFN expression (Barbalat et al., 2009; Dietrich et al., 2010) . Under these conditions, TLR2 endocytosis is necessary for IFN expression. To determine the specificity of the role of CD14 for TLR4-mediated IFN expression, we examined the expression of cytokines and IFN-regulated genes in WT and CD14-deficient cells stimulated with TLR2 ligands. Neither inflammatory monocytes nor BMDM from CD14-deficient mice displayed any defects in their responses to their diverse TLR2 ligands (Figures S1D and S1E), indicating that the role of CD14 in promoting IFN expression is specific to TLR4.
Cell Type-Specific Coexpression of TLR4 and CD14 Confers Cell Type-Specific Responses to LPS While diverse cell types are LPS responsive, not all LPS-responsive cells respond in the same manner. The molecules that dictate cell type-specific responses to LPS are unknown. We hypothesized that CD14 expression would naturally endow TLR4-bearing cells with the ability to promote TLR4 endocytosis, thus providing a mechanism of cell type-specific control over LPS-induced activities. This hypothesis was addressed by examining the expression of CD14 in cell types that are known to express TLR4 (Hoshino et al., 1999) . BMDM, immature DCs, and mouse embryonic fibroblasts (MEFs) expressed CD14, but the A20 B cell line did not (Figure 2A and Figure S2A ). Analysis of TLR4-deficient cells indicated that the surface expression of CD14 did not require TLR4 (Figure S2A) . Like BMDM and immature DCs, MEFs permitted TLR4 endocytosis in response to LPS ( Figure 2B ). In contrast, TLR4 surface levels were unchanged in A20 B cells, although these cells responded to LPS by upregulating MHC-II and CD69 ( Figure 2B and S2B). To address directly if the inability of A20 B cells to internalize TLR4 resulted from deficient CD14 expression, we transfected these cells with a plasmid encoding CD14. A20 B cells expressing CD14 gained the ability to internalize TLR4 ( Figure 2C ). These latter results are consistent with previous work showing that the B cell line Ba/F3 displays enhanced TLR4 endocytosis when CD14 is overexpressed (Tanimura et al., 2008) .
To determine if our results apply to conditions in vivo, WT and CD14-deficient mice were injected intravenously with LPS and at various times after injection, CD11c+/CD11b+ cells (DCs) or CD11c-/CD11b+, Ly6G-cells (BMDM) or CD19+ cells (B cells) were harvested from the spleen and examined for CD14 and TLR4 surface levels as a readout for receptor endocytosis. Prior to LPS injection, only DCs and BMDM (not B cells) expressed CD14 ( Figure 2D ). Splenic BMDM and DCs internalized TLR4 in response to LPS injection ( Figure 2E ), and this process was dependent on CD14. In contrast, splenic B cells were not capable of internalizing TLR4 in response to LPS injection (Figure 2E) . Notably, transfection of ex vivo cultured splenic B cells with plasmids encoding CD14 endowed these cells with the ability to internalize TLR4 ( Figure 2F ). Collectively, these data establish that the natural coexpression of CD14 and TLR4 determines which cell types internalize TLR4 in response to LPS.
CD14 Mediates the LPS-Induced Internalization of Extracellular Macromolecules
In addition to promoting TLR4 endocytosis, LPS induces DCs to undergo rapid macropinocytosis (West et al., 2004) . To determine if CD14 regulates this process, we examined the capture of fluorescent dextrans by immature DCs, BMDM, MEFs and A20 B cells by FACS. LPS induced rapid macropinocytosis of dextrans only in cells that naturally express CD14 (BMDM, DCs, and MEFs, but not A20 B cells) ( Figures 3A-3C ). Moreover, CD14 was required for LPS-induced macropinocytosis in BMDM and DCs (Figures 3A and 3B) . As expected from previous work implicating the TLR4-activated kinase Rsk in macropinocytosis (Zaru et al., 2007) , TLR4 was required for this response ( Figures 3A and 3B ).
To address directly if the macropinocytosis defects of A20 B cells results from deficient CD14 expression, we transiently transfected these cells with plasmids encoding CD14. A20 B cells expressing CD14 gained the ability to induce macropinocytosis in response to LPS ( Figure 3C ). These data suggest that the CD14-dependent endocytosis pathway functions to internalize both TLR4 and extracellular macromolecules.
The CD14-Dependent Endocytosis Pathway Is Upregulated upon DC Maturation Perhaps more than any other antigen presenting cell, the functions of DCs are tied to their endocytic capacity (Mellman and Steinman, 2001) . Recent work has demonstrated that mature DCs retain the capacity to capture and present antigens on MHC-II (Drutman and Trombetta, 2010; Platt et al., 2010) . We reasoned that if mature DCs retain the ability to capture antigens, then they should also retain the ability to respond to microbial products. We therefore determined if CD14-dependent activities are retained after DC maturation.
Immature DCs were treated with either TNFa or the TLR9 ligand CpG DNA. Each of these ligands induced the upregulation of costimulatory molecules and MHC-II in WT and CD14-deficient DCs, indicating that DC maturation does not require CD14 ( Figure 4A ). The resulting mature cells were then stimulated with LPS to examine TLR4 endocytosis and cytokine expression. Interestingly, as compared to immature DCs, LPS-induced TLR4 endocytosis was enhanced ( Figure 4B ). The enhancement of TLR4 endocytosis was impressive-mature DCs exhibited a faster rate of TLR4 endocytosis, and these cells internalized a larger percent of the total receptors ( Figure 4B ). This increase in TLR4 entry coincided with an increased production of TRIF-dependent IFNs ( Figure 4C ), but not MyD88-dependent TNFa ( Figure 4D ). A potential explanation for the maturation-induced enhancement of TLR4 endocytosis and signaling would be if the maturation stimuli triggered an increase in the expression of CD14. Consistent with this idea, we found that TNFa or CpG DNA treatment resulted in higher surface levels of CD14, compared to immature DCs ( Figure 4E ). This increase in CD14 surface levels correlated with an increase in CD14 gene expression ( Figure 4F ). The signaling pathways triggered by CpG DNA and TNFa activate NF-kB (Akira and Takeda, 2004; Muppidi et al., 2004) . Thus, the NF-kB-specific inhibitor Bay11-7085 was used to examine the role of this transcription factor in CD14 gene expression. Bay11-7085 prevented CD14 upregulation by either CpG DNA or TNFa ( Figure 4G ), suggesting that NF-kB mediates CD14 expression. Moreover, MyD88-deficient cells, which are defective for CpG DNA-induced NF-kB expression (Hemmi et al., 2000) , were incapable of upregulating CD14 upon CpG DNA treatment ( Figure 4F ). MyD88-deficient cells retained the ability to induce CD14 expression in response to TNFa ( Figure 4F ). (E) Mice were injected with LPS (50 mg) and at the times indicated spleens were isolated and BMDM, DCs, and B cells were examined for surface levels of TLR4 by flow cytometry. (F) Splenic B cells were transfected with a plasmid encoding CD14 and treated for the indicated times with LPS (1 mg/ml) before TLR4 endocytosis was examined by flow cytometry. See also Figure S2 .
Collectively, these data suggest that during DC maturation, the functions of the TLR4 signaling pathways are not just retained but enhanced, and that CD14 expression is rate limiting in the control of TLR4 endocytosis and TRIF signaling.
The Primary Function of CD14 in TRIF Signaling Is to Deliver TLR4 to Endosomes We reasoned that if the primary function of CD14 in mediating TRIF signaling is to promote TLR4 endocytosis, then delivering TLR4 to endosomes independently of CD14 should restore IFN expression in CD14-deficient cells. In contrast, if CD14 must physically change the conformation of TLR4 to permit TRIF signaling (Jiang et al., 2005) , then altering TLR4 localization would not restore IFN expression to CD14-deficient cells. This prediction was tested by taking advantage of the fact that some TLRs will be nonspecifically internalized into phagosomes (Underhill et al., 1999) . Thus, whole E.coli bacteria was used as an alternative source of LPS. BMDM and DCs derived from WT, CD14-deficient and TLR4-deficient mice all internalized E.coli to similar extents ( Figures 5A and 5B) , and the expression of MyD88-dependent TNFa was similar in WT and CD14-deficient cells ( Figures 5C and 5E ). TLR4-deficient cells produced no cytokines or IFNs in response to E.coli ( Figures 5C and 5E ).
Interestingly, E.coli treatment induced TLR4 endocytosis and IFN expression in both WT and CD14-deficient DCs ( Figures  5C and 5D ). Similarly, LPS-coated latex beads induced the endocytosis of TLR4 in WT and CD14-deficient DCs (Figures 5G and 5H) . Although the total percent of TLR4 internalized using LPS-coated beads was low when compared to soluble LPS, these particles restored IFN expression to CD14-deficient DCs 
CD14 Is Required for LPS-Induced Macropinocytosis
Macropinocytosis was measured in DCs (A) or BMDM (B) by flow cytometry. Cells were untreated or treated for the times indicated with fluorescent dextrans (1 mg/ml) in the presence or absence of LPS (1 mg/ml). Cell-associated fluorescence intensity was then compared between LPS-treated and untreated cell populations to determine changes from the steady state levels of macropinocytosis. Note that both CD14 and TLR4 are required for LPSinduced macropinocytosis. (C) MEFs or A20 B cells were untreated or treated for the times indicated with fluorescent dextrans (1 mg/ml) in the presence or absence of LPS (1 mg/ml). Cell associated fluorescence intensity was then compared between LPS-treated and untreated populations of cells to determine changes from the steady state levels of macropinocytosis.
to a level comparable to WT cells (Figures 5G and 5H) . These data indicate that in DCs, the primary function of CD14 in IFN expression is to deliver TLR4 to endosomes where TRIFdependent signaling can occur. The ability of phagocytic cargo to bypass the need for CD14 in promoting IFN expression was not universal, however. In contrast to DCs, phagocytic particles were unable to induce IFN expression in CD14-deficient BMDM ( Figures  5E and 5F ). To explain these cell type specific differences, we determined if TLR4 was internalized by CD14-deficient BMDM upon exposure to beads or E.coli. Unlike DCs, TLR4 surface levels remained constant in CD14-deficient BMDM treated with either E.coli or LPS-coated beads ( Figure 5F and data not shown). Interestingly, the difference between BMDM and DCs in their ability to internalize TLR4 during phagocytosis was not unique to this receptor. Under similar experimental conditions, FcgR1 was also internalized by DCs, but not BMDM, even though no opsonin was used in these studies ( Figure S3A ). These data suggest that DCs are intrinsically more ''permissive'' than BMDM in terms of allowing receptors to enter the cell during phagocytosis. While the molecular basis for this distinction remains unknown, these observations provide a plausible explanation for why LPS-coated particles can rescue the transport and signaling defects of CD14-deficient DCs but not BMDM.
CD14 Induces a Syk/PLCg2-Dependent Endocytosis Pathway that Promotes the Internalization of TLR4
We sought to identify regulators of CD14-dependent endocytosis. To determine if TLR4 signaling was required for its own transport, TLR4 endocytosis was examined in cells lacking individual TIR domain containing adaptors (Akira and Takeda, 2004) . The endocytosis of TLR4 was unaffected by the lack of MyD88, TRIF, TIRAP or TRAM in DCs or BMDM ( Figure S4A and data not shown). In addition, cells lacking MyD88 and TRIF, which are defective for all TLR4-dependent activities (Hirotani et al., 2005) , retained the ability to internalize TLR4 in response to LPS ( Figure 6A ). Similar results were obtained when examining TLR4 endocytosis in DCs or BMDM derived from the C3H/HeJ mouse ( Figure 6A ), which contain a point mutation in the TLR4 TIR domain that abolishes its signaling potential (Poltorak et al., 1998) . Thus, neither a signaling competent TIR nor the signaling adaptor proteins are necessary for LPS-induced TLR4 endocytosis.
These data suggest the existence of an LPS-inducible endocytic process that is CD14-dependent but TLR4-signaling independent. Upon LPS treatment, CD14 can act independently of (A) DCs were untreated or treated for 18 hr with CpG DNA (1 mM) or TNFa (100 pg/ml). DC maturation was then assessed by flow cytometry by determining the increase in surface staining of CD86, CD40, or MHC class II.
(B) Immature DCs or DCs matured for 18 hr with CpG DNA (1 mM) or TNFa (100 pg/ml) were treated with LPS (1 mg/ml) and TLR4 endocytosis was measured by flow cytometry at the times indicated. Displayed are the MFIs of specific surface TLR4 staining at each time point.
(C and D) Immature DCs or DCs matured for 18 hr with CpG DNA (1 mM) or TNFa (100 pg/ml) were treated with LPS at the concentrations indicated and the production of the indicated cytokines were measured after 18 hr. (E) DCs were either untreated or treated for 18 hr with CpG DNA (1mM) or TNFa (100 pg/ml) and the effect of these stimuli on the cell surface levels of CD14 was assessed by flow cytometry.
(F) DCs of the genotypes indicated were processed as described in (E). After 18 hr, CD14 mRNA levels were determined by qPCR.
(G) DCs were stimulated with the ligands indicated as described in (E) in the presence of absence of the NF-kB inhibitor Bay11-7085 and then processed to measure CD14 expression by qPCR. (C) DCs were treated with E.coli at the MOIs indicated on the x axis, and the production of the indicated cytokines were measured after 18 hr. (D) DCs were treated with E.coli at an MOI of 10 or LPS (1 mg/ml) and TLR4 endocytosis was measured by flow cytometry at the times indicated. Displayed are the MFIs of specific surface TLR4 staining at each time point. (E) BMDM were treated with E.coli at the MOIs indicated on the x axis, and the production of the cytokines indicated were measured. (F) BMDM were treated with E.coli at an MOI of 10 or LPS (1 mg/ml) and TLR4 endocytosis was measured by flow cytometry at the times indicated. Displayed are the MFIs of specific surface TLR4 staining at each time point. (G) DCs were treated with either LPS-coated latex beads or uncoated beads and the production of the cytokines indicated were measured. (H) DCs were treated with either LPS-coated latex beads or uncoated beads in the presence of soluble LPS and TLR4 endocytosis was measured by flow cytometry at the times indicated. Displayed are the MFIs of specific surface TLR4 staining at each time point. See also Figure S3 . (A) Immortal BMDM or primary macrophages and DCs of the genotypes indicated were either untreated or treated with LPS (1 mg/ml) for the times indicated. Flow cytometry was then used to examine receptor endocytosis by determining the surface levels of the endogenous TLR4. Shown are the MFIs of specific TLR4 surface staining at each time point indicated.
(B and C) BMDM (B) or DCs (C) of the genotypes indicated were treated with 10 ng/ml LPS for the times indicated and the rate of TLR4 endocytosis was assessed by flow cytometry (first panel). Second and third panels: cells were stimulated with 10 ng/ml LPS for 18 hr and the amounts of secreted cytokines were determined. (D) The cells indicated were treated with the Src inhibitor in the presence or absence of LPS (10 ng/ml) and the rate of TLR4 endocytosis was monitored by flow cytometry. (E) BMDM were treated with the Syk inhibitor piceatannol (75 mM) and were then stimulated with 10 ng/ml LPS. At the times indicated, the rate of TLR4 endocytosis was assessed by flow cytometry (first panel). Second and third panels: cells were stimulated in the presence or absence of piceatannol with 10 ng/ml LPS for 18 hr, and the amounts of secreted cytokines were determined. Fourth panel: BMDM were treated with LPS (1 mg/ml) for 30 min in the presence or absence of piceatannol (75 mM). The presence of dimerized IRF3 and IkBa was assessed by western analysis. (F) BMDM of the genotypes indicated were treated with 10 ng/ml LPS for either 30 or 90 min. The rate of TLR4 endocytosis was assessed by flow cytometry (first panel). Second and third panels: cells were stimulated with 10 ng/ml LPS for 18 hr, and the amounts of secreted cytokines were determined. See also Figure S4 .
TLR4 to induce the influx of Ca
2+ from the extracellular environment (Zanoni et al., 2009 ). This process is mediated by the enzyme PLCg2. PLCg2 is a regulator of endocytosis (Botelho et al., 2000; Depoil et al., 2009 ) and is thus a candidate regulator of TLR4 endocytosis. To determine if PLCg2 is involved in TLR4 endocytosis, we examined the transport of the receptor in cells lacking PLCg2. When compared to WT cells, PLCg2-deficient BMDM and DCs were defective for LPS-induced TLR4 endocytosis ( Figures 6B and 6C) , although the defect was not as profound as that observed in CD14-deficient cells. Similar results were obtained in WT cells treated with the PLC-specific inhibitor U73122 (Figures S4B and S4C ). This defect in TLR4 transport was most impressive at early time points after LPS treatment, suggesting that PLCg2 regulates the primary pathway of TLR4 endocytosis and may therefore be important for signaling events that occur from endosomes. Consistent with this prediction, PLCg2-deficient cells, or WT cells treated with the PLC inhibitor, were deficient in IFN expression (Figures 6B and 6C and Figures S4B and S4C) . TNFa production was unaffected by the lack of PLCg2. Overall these results largely phenocopy those obtained with CD14-deficient cells and thus implicate PLCg2 in CD14-dependent endocytosis.
As Src family members provide a molecular link between CD14 and PLCg2 for LPS-induced Ca 2 mobilization (Zanoni et al., 2009 ), we determined if TLR4 endocytosis was sensitive to chemical inhibitors of this kinase family. Src inhibitors did not effect TLR4 endocytosis ( Figure 6D ). We also ruled out a role for extracellular Ca 2 , as experiments performed in the presence of the Ca 2 chelator EGTA did not prevent TLR4 endocytosis (data not shown). Thus, the CD14-dependent/TLR4-independent responses described previously (Zanoni et al., 2009 ) are distinct from those that lead to TLR4 endocytosis. In addition to the Src family, the tyrosine kinase Syk is upstream of PLCg2 (Crowley et al., 1997; Depoil et al., 2009) . To determine if Syk is involved in CD14-dependent endocytosis, WT cells were treated with two distinct Syk-specific inhibitors, piceatannol and Bay61-3606. Similar to the results obtained with PLCg2-deficient cells, treatment with either inhibitor diminished TLR4 endocytosis and IFN production, whereas TNFa expression remained intact ( Figure 6E and Figures S4D and S4E) . Moreover, in both BMDM and DCs, Syk inhibition prevented the LPS-induced activation of IRF3 but not the degradation of IkB ( Figure 6E and Figure S5A ). Thus, like CD14, Syk and PLCg2 are required for LPS-induced TLR4 endocytosis and signaling from endosomes but not MyD88-dependent signaling from the plasma membrane.
Activation of Syk-dependent pathways usually involves a membrane protein that contains an immunoreceptor tyrosinebased activation motif (ITAM) (Lowell, 2010) . The ITAM containing transmembrane adaptors DAP12 and FcεRIg are involved in TLR4 signaling (Chu et al., 2008; Hamerman et al., 2005) . Since CD14 contains neither an ITAM, nor a transmembrane domain, we considered the possibility that ITAM-containing adaptors would be necessary for CD14-dependent TLR4 endocytosis. We examined the transport and signaling of TLR4 in cells lacking both DAP12 and FcεRIg (Chu et al., 2008) . Compared to WT cells, BMDM and DCs derived from mice doubly deficient in DAP12 and FcεRIg displayed delayed TLR4 endocytosis and expressed low levels of TRIF-dependent IFN expression ( Figure 6F and Figure S5B ). MyD88-dependent TNFa expression was unaffected by the lack of ITAM-containing adaptors ( Figure 6F and Figure S5B ). These data support the idea that CD14 activates an ITAM-mediated event that triggers the Syk-PLCg2 mediated endocytosis of TLR4.
If Syk was truly involved in CD14-dependent endocytosis of TLR4, then this kinase should be activated by LPS in a manner dependent on CD14. This was first addressed using western analysis for the presence of phosphorylated Syk. BMDM stimulated with LPS induced the appearance of phospho-Syk, by a process dependent on CD14 ( Figure 7A ). To complement this approach, we utilized flow cytometry to detect phospho-Syk after stimulation of cells with either LPS or the known Syk activator curdlan (Rogers et al., 2005; Underhill et al., 2005) . LPS and curdlan both induced comparable amounts of phosphoSyk ( Figure 7B ). Interestingly, Syk-phosphorylation did not occur in CD14-deficient BMDM or DCs stimulated with LPS, whereas curdlan-induced Syk-phosphorylation was unaffected by the lack of CD14 ( Figure 7B ). Moreover, cells derived from the C3H/HeJ mouse that harbor a signaling defective TLR4 protein retained the ability to induce Syk activation ( Figure 7B ). Collectively, these data demonstrate that Syk is activated by a CD14-dependent process that does not require TLR4.
Finally, a microscopic approach was used to examine the role of Syk in CD14-dependent endocytosis. Unfortunately, the antibody used to detect TLR4 is not suitable for biochemical or microscopic techniques. In fact, there are few (if any) antibodies available that can detect TLR4 reliably. CD14-specific antibodies are reliable and have been useful tools in many applications. To determine if CD14 would serve as a marker for Syk-dependent endocytosis, we examined the requirements for CD14 internalization in response to LPS. Using FACS as a preliminary readout for CD14 endocytosis, we found that LPS induced CD14 endocytosis by a process independent of TLR4 or its signaling adaptors, but was inhibited by Syk or PLC-specific inhibitors ( Figures  S5C-S5E) . Thus, CD14 and TLR4 are internalized by a similar process and validate the utility of using CD14 as a marker of Syk-dependent endocytosis. By confocal microscopy, CD14 labeled the surface of BMDM with a concentration in membrane ruffles ( Figure 7C ). Within 3 min of LPS treatment, CD14 appeared in macropinosomes that costained with cholera toxin B (CTB), which marks GPI rich regions of the plasma membrane and endosomes ( Figure 7C ). CD14 and CTB costaining persisted for up to 30 min, but these endosomes never colocalized extensively with tubular dextran-loaded late endocytic vesicles (Figure 7C) . LPS-induced macropinosomes stained positive for the early endosomal marker EEA1 ( Figure S5F ). When cells were treated with the Syk inhibitor piceatannol, CD14 remained at the plasma membrane and was poorly internalized (Figure 7C ), and no enlarged EEA1 positive macropinosomes were observed ( Figure S5F ). These data are very similar to that obtained by FACS and thus further validate the existence of a Syk-dependent endocytic pathway that is triggered by LPS.
DISCUSSION
The role of endocytosis in TLR signaling has attracted much attention in recent years. Despite its importance, the only known (A) BMDM of the genotypes indicated were stimulated with LPS (100 ng/ml). At the times indicated, the presence of phospho-Syk was examined by western blot. (B) BMDM and DCs of the genotypes indicated were stimulated with either LPS or curdlan and the presence of phospho-Syk was detected by flow cytometry. (C) BMDM were stimulated with LPS (100 ng/ml) for the times indicated and processed for confocal microscopy to detect the presence of CD14, Cholera Toxin B (CTB) or dextran loaded lysosomes. All images for all panels are representative of at least three independent experiments where over 500 cells were examined per condition and > 95% of the cells displayed similar staining. (D) Model depicting a cascade of transport events that is mediated by CD14 in order to promote TLR4 signaling. CD14 first captures and transports LPS to the plasma membrane localized complex of TLR4 and MD2, which signals through the TIRAP-MyD88 adaptors to activate inflammatory cytokine expression. CD14 then transports TLR4 to endosomes by a process mediated by Syk and PLCg2, where TRAM-TRIF signaling can lead to the expression of IFNs. See also Figure S5 .
regulators of TLR endocytosis are dynamins, clathrin and their associated proteins (Husebye et al., 2006; Kagan et al., 2008) . While these regulators control many general endocytic processes, they cannot provide insight into the specific means by which microbial products can induce TLRs to enter mammalian cells. Our discovery that the LPS-binding protein CD14 is a regulator of TLR4 endocytosis therefore fills an important gap in our knowledge of how microbial binding can be coordinated with TLR endocytosis.
CD14 was identified originally as being important for MyD88-dependent signal transduction (Moore et al., 2000; Wright et al., 1990) . As many others have reported, we have found that CD14 is only necessary for MyD88-dependent signaling at low concentrations of LPS, an observation that is likely explained by the function of this PRR in transporting LPS to the TLR4-MD-2 complex (da Silva Correia et al., 2001; Gioannini et al., 2004) . The LPS-transport and TLR4-transport functions of CD14 can be distinguished by the means by which we can bypass their requirement in TLR4 signaling. For example, while the defects in MyD88-dependent TNFa expression can be rescued by increasing the concentration of LPS (Perera et al., 1997) , the defects in TLR4 endocytosis and TRIF signaling cannot. These data clearly distinguish the two roles of CD14, one in transporting LPS to the receptor (which can be overcome by increasing LPS dose) and one in transporting the receptor into the cell (which can be overcome by forcing the receptor into phagosomes of DCs). Taken together these data suggest that CD14 initiates a cascade of trafficking events ( Figure 7D ). This cascade begins with CD14 transporting LPS to TLR4 and culminates with CD14 delivering TLR4 to the endosomal signaling machinery that is needed to induce IFN expression ( Figure 7D ). This ''innate immune trafficking cascade'' may also apply to other nonsignaling PRRs that function to deliver microbial ligands to downstream PRRs with signaling capabilities. Since CD36 and the Mannose Binding Lectin are thought to serve analogous functions to CD14 for TLR2 (Hoebe et al., 2005; Ip et al., 2009) , this suggestion may explain why CD14 is not required for TLR2-mediated IFN expression.
CD14 is not only required for TLR4 endocytosis in naive antigen presenting cells, but also in mature DCs. When compared to immature DCs, mature DCs exhibited an enhanced capacity to internalize TLR4 and induce the expression of TRIF-dependent genes. All of these activities were dependent on CD14 and were observed in DCs matured with either self-encoded or microbial ligands. These data suggest that CD14-dependent endocytosis is broadly important for the functions of both immature and mature DCs. In addition, our data reveal that mature DCs retain the ability to sense and respond to microbial encounters. CD14 has recently been implicated in regulating the differentiation of monocyte-derived DCs (Mo-DCs) upon encountering LPS (Cheong et al., 2010) . Once differentiated, Mo-DCs express high levels of CD14 and are potent antigen presenting cells. Thus, a trend is emerging whereby mature DCs exhibit higher levels of CD14 expression than their immature counterparts, and we suspect that the function of this activity is to enhance the ability of Mo-DCs to induce T cell differentiation.
For many years, TLR4 has been considered the sole mediator of CD14-dependent responses because all well-studied activities of LPS were dependent on TLR4 and its signaling adaptors. Thus, after delivery of LPS to TLR4, it is thought that the function of CD14 is complete and TLR4 can then act independently of any extracellular factors to promote MyD88 and TRIF signaling. Our discovery that TLR4 actually depends on CD14 for its own endocytosis represents a significant shift in our understanding of the hierarchy of PRRs that regulate responses to endotoxin. Since TLR4 is cargo for a CD14-dependent endocytic pathway, we propose that TLR4 is not the ''king'' of all LPS responses. Rather, TLR4 is subservient to CD14 and must rely on this upstream PRR to not only receive its ligand (LPS) but also to be delivered to endosomes where TRIF-mediated signaling can occur. Thus, CD14 sits at the apex of all cellular responses to LPS and functions to induce an innate immune trafficking cascade that involves the transport of both TLR4 and its ligand LPS.
The endocytic pathway activated by CD14 appears to be ITAM-mediated, and requires Syk and its downstream effector PLCg2. Evidence in support of this claim comes from observations that inhibition of either Syk or PLCg2 largely phenocopy CD14-deficiency. Moreover, our finding that CD14 is necessary for Syk-activation in response to LPS provides a direct biochemical link between CD14 and this kinase. It is possible that conditions exist whereby alternative pathways would play a role in promoting the delivery of TLR4 to endosomes, where TRIF signaling can occur. In this regard, we would like to emphasize that our use of the term endosomes does not exclude a possibility that TLR4 signaling may also occur from macropinosomes, which can be formed upon LPS treatment and are likely important in promoting the capture of microbial products. However, since TRIF signaling can occur from at least two distinct endosomal vesicles (endosomes and phagosomes), it is unlikely that TRIF signaling would be restricted to macropinosomes or any specific type of endosome. Rather, we suggest that the TLR4 network is designed such that any means of generating a TLR4 containing endosomal vesicle is sufficient to induce TRIF signaling. The possible number of different means by which TLR4 can be delivered into endosomes is difficult to predict, as evidenced by our unexpected finding that even when using a common means of internalization (phagocytosis), BMDM and DCs differ in their ability allow TLR4 and FcgR1 to enter phagosomes. Despite this possibility of endocytic heterogeneity, the fact that the CD14-PLCg2-Syk pathway is activated specifically by LPS suggests that this pathway represents the primary means of promoting TLR4 internalization and signaling in cell types as diverse as phagocytes and fibroblasts.
From an evolutionary perspective, our identification of Syk and PLCg2 as regulators of LPS-induced endocytosis draws similarities to other immunity-related endocytosis receptors that also depend on these factors, such as Dectin-1 and FcgR1 (Crowley et al., 1997; Rogers et al., 2005; Underhill et al., 2005) . A unifying theme that could link these observations is the idea of an ''inflammatory endocytosis pathway'' that is mediated by Syk/PLCg2 and can be engaged by diverse upstream receptors. Our work provides a mandate to consider the role of this potential inflammatory endocytosis pathway in diverse pathogenic interactions.
EXPERIMENTAL PROCEDURES
Mice, Cells, and Transfection C57BL/6 mice were from Harlan-Italy. Cd14 À/À mice were from CNRS d'Orlé ans (Orlé ans Cedex 2, France). OT-II mice were from Charles River. Tlr4 À/À C57BL/6 mice were provided by S. Akira (Osaka University, Japan). PLCg2 deficient mice were provided by A. Mocsai (Semmelweis University, Hungary). Bone marrow cells from mice lacking DAP12 and FcεRIg was kindly provided by M. Colonna (Washington University, St. Louis). All experiments were carried out in accordance with the relevant laws and institutional guidelines. E. coli O111 was from ATCC-LGC. DCs and BMDM were derived from bone marrow of C57BL/6 or mutant mice. DCs were collected after 7-8 days of culture in 10% B16-GM-CSF conditioned medium when CD11c expression, assessed by flow cytometry, was higher than 90%. BMDM were used after 6 days of culture in 30% M-CSF conditioned medium. A20 cells and freshly isolated splenic B cells were transfected with pCDNA3-based vector encoding CD14 by nucleofection (AMAXA) using the Nucleofector Buffer V and program L-013.
Antibodies and Chemicals
Anti-TLR4 antibody (Sa15-21) was labeled with biotin by BioLegend (San Diego, California). Anti-mouse CD14 was from eBioscience (San Diego, California) and anti-CD14 was from Miltenyi Biotec. Anti-Phospho-Syk (C87C1) antibody was from Cell Signaling Technology (Beverly, MA). All the other antibodies and streptavidin-conjugates used for FACS analysis were purchased from BioLegend (San Diego, California). TLR4-grade LPS (E.Coli, 055:B5) was from Alexis Biochemicals-Enzo Life Science (Farmingdale, New York). Recombinant (r)TNF was from R&D Systems (Minneapolis, USA). CpG DNA (tccatgacgttcctgatgct) was from Primm (Milan, Italy). Curdlan was from WAKO Pure Chemicals (Osaka, Japan). U73122, Piceatannol, BAY 61-3606 and BAY 11-7085 were from Sigma Aldrich (St. Louis, MO). Fluoresbrite Carboxy YG 4.5mm latex beads were from Polysciences (Warrington, PA). For adsorption of LPS onto latex beads, microspheres were resuspended in LPS (1mg/ml) and incubated overnight at 4 C. Latex beads were then washed 15 times in large volumes of sterile endotoxin-free PBS.
Western Blotting 2.5 3 10 6 cells were subjected to the indicated treatment and lysed with a buffer containing 1% NP-40, 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10% glycerol, and protease/phosphatase inhibitors (Roche). Cleared lysates were electrophoresed and immunoblotted with the indicated antibodies using standard conditions. IRF3 dimerization assay by native page was performed as described with minor modifications (Iwamura et al., 2001) . Briefly, 2.5 3 10 6 cells were lysed for 15 0 at 4 C with a buffer containing 1% NP-40, 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, protease/phosphatase inhibitors (Roche), and lysates were cleared by centrifugation at 13,000 3 g for 15 0 at 4 C. Before sample loading, 7% polyacrylamide gels were prerun for 30 0 at 40mA with 25 mM Tris, 192 mM glycine (pH 8.4) with and without 1% deoxycholate (DOC) in the cathode and anode chamber, respectively. 15mg of samples in a native sample buffer (10 mg protein, 62.5mM Tris-Cl, pH 6.8, 15% glycerol and 1% DOC) were applied to the gel and electrophoresed for 2-3 hr at 10-15 mA. Immunoblotting was performed using standard conditions.
Coimmunoprecipitation
Approximately 2*10 7 cells were lysed with a buffer containing 1% NP-40, 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10% glycerol and protease/phosphatase inhibitors (Roche). After clearing by centrifugation at 16000 x g for 15 0 at 4 C, whole cell extracts (INPUT) were quantified with a BCA kit (ThermoScientific) and 1.5 mg of this fraction were immunoprecipated overnight using Protein A Sepharose 4 Fast Flow (GE Healthcare) and 1 mg of rabbit antiMyD88 (R&D). Immunoprecipated and nonimmunoprecipated material were referred to as IP and FT (flowthrough), respectively. All fractions were then subjected to SDS-PAGE and immunoblotting was performed with anti-MyD88 and anti-IRAK4 antibodies according to standard procedures.
Cell Purification, Activation, and FACS Staining B cells were freshly isolated from the spleen of WT animals by positive selection of CD19 + cells using MACS beads (Miltenyi Biotec). For in vitro stimulations, DCs (unstimulated or matured for 18 hr with 1mM CpG or 100pg/ml rTNFa), BMDM, A20 B cells, freshly isolated splenic B cells and MEFs were treated with the various concentrations of LPS, E. coli or latex beads at the appropriate MOI for the times indicated at 37 C. Cells were then washed with ice-cold PBS and stained with the appropriate primary antibodies for 30 min on ice, followed by streptavidin-APC. Staining was assessed with a FACSCalibur (Becton Dickinson). Syk phosphorylation in DCs and BMDM treated with LPS (1 mg/ml) or Curdlan (100 mg/ml) was assessed by FACS as previously described (Underhill et al., 2005) . For in vivo stimulations, WT, CD14-, or TLR4-deficient mice were i.v. injected with 50 mg of LPS and, at the indicated times, spleens were collected, red-blood cells lysed, and unicellular suspensions stained as described above.
TNFa and IFN Measurements ELISA for TNFa was performed using the DuoSet kit (R & D, Minneapolis, MN). IFN activity was measured as described (Dixit et al., 2010) .
Real-Time Quantitative PCR Total RNA was extracted from 3 3 10 6 cells using the TRIZOL reagent according to the recommended procedure (GIBCO-BRL). Single-strand cDNA was synthesized using High-capacity cDNA Reverse Transcription Kits (Perkin-Elmer, Applied Biosystem Division, Foster City, CA). The NanoDrop (TermoScientific) was used to titer mRNA and amplification was performed using the Power Sybr Green PCR Master Mix (Perkin Elmer).
Statistical Analysis
Means were compared by paired or unpaired t tests. Data are expressed and plotted as means ± ES values. Sample sizes for each experimental condition are provided in the Experimental Procedures and the figure legends.
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